COVID-19 has been associated with alterations in coagulation. Recent reports have shown
that protein C and S activities are altered in COVID-19. This may affect the complications …

Purpose Pulmonary emboli (PE) contribute substantially to coronavirus disease 2019
(COVID-19) related mortality and morbidity. Immune cell-mediated hyperinflammation drives …

Abstract Background Prostaglandin E 2 (PGE 2) and leukotriene B 4 (LTB 4) are
eicosanoids involved in modulation of the antiviral immune response. Recent studies have …

Background From asymptomatic to acute and life-threatening pulmonary infection, the
clinical manifestations of COVID-19 are highly variable. Interleukin (IL)-6 and IL-17A are key …

The traceability of in vitro diagnostics or drug products is based on the accurate
quantification of proteins. In this study, we developed an absolute quantification approach …

Endocan is an endothelial-cell-specific proteoglycan (ESM-1) and has emerged as an
endothelial dysfunction and inflammatory marker in recent years. Endocan can be used as a …

The SARS-CoV-2 virus may cause severe infection, which is associated with diverse clinical
manifestations. Vitamin D has immunomodulating properties and may enhance the body's …

Background: Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that displays great …

The accuracy of the classic scores that help stratify the pretest clinical probability of
pulmonary embolism (PE) in SARS-CoV-2 infection (COVID-19) is low. Therefore, to …

Objective This study aims to investigate the impact of the infection with the novel coronavirus
Omicron variant on the outcomes of patients with severe spontaneous intracerebral …